C19-YRS becomes the first Clinically Validated Outcome Measure for use in Long COVID Patients

C19-YRS logo 200x200

ELAROS is pleased to announce on behalf of our C19-YRS clinical partners the first global study that examines the psychometric properties of an outcome measure in patients with Post COVID Syndrome (Long COVID). In this sample of patients, the C19-YRS was clinically useful and satisfied standard psychometric criteria, providing preliminary evidence of its suitability as a measure of Post COVID Syndrome.